“This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. 

The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.

The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 

Lead Edge Capital is a well-known tech investor that has previously worked with such groups as Spotify, Duo Security and Toast.

Teams from the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine will collaborate on the research. 

Cardiovascular Associates of America, which calls Orlando home, has made increasing its presence in the Sunshine State a top priority in 2023.

CMS also floated the idea of pausing the AUC program until a better implementation strategy could be put into place. 

Versanis, founded in 2021 by a venture capital firm, is primarily known as the company behind the obesity drug bimagrumab.